ArticleCancer immunology research2017

SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.

Jungsun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.